US20020136789A1 - Use of tagetes minuta oil and its components as antiviral agents - Google Patents
Use of tagetes minuta oil and its components as antiviral agents Download PDFInfo
- Publication number
- US20020136789A1 US20020136789A1 US09/765,075 US76507501A US2002136789A1 US 20020136789 A1 US20020136789 A1 US 20020136789A1 US 76507501 A US76507501 A US 76507501A US 2002136789 A1 US2002136789 A1 US 2002136789A1
- Authority
- US
- United States
- Prior art keywords
- oil
- virus
- ocimene
- dihydrotagetone
- tagetes minuta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000429223 Tagetes minuta Species 0.000 title claims abstract description 41
- 235000003595 Tagetes minuta Nutrition 0.000 title claims abstract description 40
- 239000003443 antiviral agent Substances 0.000 title description 4
- VUSBHGLIAQXBSW-UHFFFAOYSA-N 2,6-dimethyloct-7-en-4-one Chemical compound CC(C)CC(=O)CC(C)C=C VUSBHGLIAQXBSW-UHFFFAOYSA-N 0.000 claims abstract description 62
- 241000700605 Viruses Species 0.000 claims abstract description 52
- 241000196324 Embryophyta Species 0.000 claims abstract description 34
- 238000011282 treatment Methods 0.000 claims abstract description 30
- 230000000840 anti-viral effect Effects 0.000 claims abstract description 27
- IHPKGUQCSIINRJ-NTMALXAHSA-N (Z)-beta-ocimene Chemical compound CC(C)=CC\C=C(\C)C=C IHPKGUQCSIINRJ-NTMALXAHSA-N 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 16
- 239000000470 constituent Substances 0.000 claims abstract description 8
- 241000723666 Carnation ringspot virus Species 0.000 claims description 25
- 240000006497 Dianthus caryophyllus Species 0.000 claims description 16
- 235000009355 Dianthus caryophyllus Nutrition 0.000 claims description 16
- 210000003462 vein Anatomy 0.000 claims description 4
- 241000723672 Dianthovirus Species 0.000 claims description 3
- 241000710078 Potyvirus Species 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003921 oil Substances 0.000 description 54
- 238000012360 testing method Methods 0.000 description 35
- 239000000341 volatile oil Substances 0.000 description 34
- 230000003902 lesion Effects 0.000 description 32
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 22
- 241001635862 Carnation vein mottle virus Species 0.000 description 22
- 150000007823 ocimene derivatives Chemical class 0.000 description 21
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 description 21
- 230000005764 inhibitory process Effects 0.000 description 19
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 12
- 241000723873 Tobacco mosaic virus Species 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- 229960000329 ribavirin Drugs 0.000 description 10
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 10
- 240000002754 Chenopodium giganteum Species 0.000 description 8
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- 235000008091 Chenopodium giganteum Nutrition 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 6
- 241000366182 Melaleuca alternifolia Species 0.000 description 6
- 235000012308 Tagetes Nutrition 0.000 description 6
- 241000736851 Tagetes Species 0.000 description 6
- 229930014626 natural product Natural products 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 5
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000000638 solvent extraction Methods 0.000 description 5
- 240000006162 Chenopodium quinoa Species 0.000 description 4
- 235000015493 Chenopodium quinoa Nutrition 0.000 description 4
- 240000003768 Solanum lycopersicum Species 0.000 description 4
- VCCRNZQBSJXYJD-UHFFFAOYSA-N galangin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=CC=C1 VCCRNZQBSJXYJD-UHFFFAOYSA-N 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 4
- FVRDYQYEVDDKCR-DBRKOABJSA-N tiazofurine Chemical compound NC(=O)C1=CSC([C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)=N1 FVRDYQYEVDDKCR-DBRKOABJSA-N 0.000 description 4
- 229960003723 tiazofurine Drugs 0.000 description 4
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241000710076 Bean common mosaic virus Species 0.000 description 3
- 241000723346 Cinnamomum camphora Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 241000710117 Southern bean mosaic virus Species 0.000 description 3
- 208000036142 Viral infection Diseases 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229930008380 camphor Natural products 0.000 description 3
- 229960000846 camphor Drugs 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 230000001338 necrotic effect Effects 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 210000002845 virion Anatomy 0.000 description 3
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- YGHRJJRRZDOVPD-UHFFFAOYSA-N 3-methylbutanal Chemical compound CC(C)CC=O YGHRJJRRZDOVPD-UHFFFAOYSA-N 0.000 description 2
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000607519 Aeromonas sp. Species 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 241000010789 Callistemon lanceolatus Species 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 244000302413 Carum copticum Species 0.000 description 2
- 235000007034 Carum copticum Nutrition 0.000 description 2
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 2
- 241000219312 Chenopodium Species 0.000 description 2
- 241000723655 Cowpea mosaic virus Species 0.000 description 2
- 241000724252 Cucumber mosaic virus Species 0.000 description 2
- 244000287189 Dianthus barbatus Species 0.000 description 2
- 235000005404 Dianthus barbatus Nutrition 0.000 description 2
- 241000255925 Diptera Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 2
- 241001506371 Kadsura Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 241001495644 Nicotiana glutinosa Species 0.000 description 2
- 235000004072 Ocimum sanctum Nutrition 0.000 description 2
- 240000002837 Ocimum tenuiflorum Species 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- XESARGFCSKSFID-UHFFFAOYSA-N Pyrazofurin Natural products OC1=C(C(=O)N)NN=C1C1C(O)C(O)C(CO)O1 XESARGFCSKSFID-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000780602 Senecio Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 description 2
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 206010014599 encephalitis Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- CIPSYTVGZURWPT-UHFFFAOYSA-N galangin Natural products OC1=C(Oc2cc(O)c(O)cc2C1=O)c3ccccc3 CIPSYTVGZURWPT-UHFFFAOYSA-N 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229930014550 juvenile hormone Natural products 0.000 description 2
- 239000002949 juvenile hormone Substances 0.000 description 2
- 150000003633 juvenile hormone derivatives Chemical class 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 2
- SUYJZKRQHBQNCA-UHFFFAOYSA-N pinobanksin Natural products O1C2=CC(O)=CC(O)=C2C(=O)C(O)C1C1=CC=CC=C1 SUYJZKRQHBQNCA-UHFFFAOYSA-N 0.000 description 2
- XESARGFCSKSFID-FLLFQEBCSA-N pirazofurin Chemical compound OC1=C(C(=O)N)NN=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 XESARGFCSKSFID-FLLFQEBCSA-N 0.000 description 2
- 229930006696 sabinene Natural products 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 229960003636 vidarabine Drugs 0.000 description 2
- 229940100050 virazole Drugs 0.000 description 2
- USMNOWBWPHYOEA-XKSSXDPKSA-N (+)-beta-thujone Chemical compound O=C([C@H]1C)C[C@@]2(C(C)C)[C@@H]1C2 USMNOWBWPHYOEA-XKSSXDPKSA-N 0.000 description 1
- 229930007107 (+)-beta-thujone Natural products 0.000 description 1
- UDYGWSPUYSRWRN-AGLLBGTNSA-N (2e,4e)-3,7-dimethylocta-2,4,6-trienal Chemical compound CC(C)=C\C=C\C(\C)=C\C=O UDYGWSPUYSRWRN-AGLLBGTNSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- GEWRKGDRYZIFNP-UHFFFAOYSA-N 1h-1,3,5-triazine-2,4-dione Chemical compound OC1=NC=NC(O)=N1 GEWRKGDRYZIFNP-UHFFFAOYSA-N 0.000 description 1
- XUDNWQSXPROHLK-OACYRQNASA-N 2-phenyl-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC=CC=2)OC2=CC=CC=C2C1=O XUDNWQSXPROHLK-OACYRQNASA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N 3‐isothujone Chemical compound CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 241000219224 Acer pictum subsp. okamotoanum Species 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 244000296825 Amygdalus nana Species 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 241001530056 Athelia rolfsii Species 0.000 description 1
- 241000702286 Bean golden mosaic virus Species 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Camphene hydrate Chemical compound C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000714206 Carnation mottle virus Species 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 241000282552 Chlorocebus aethiops Species 0.000 description 1
- 241000222201 Colletotrichum capsici Species 0.000 description 1
- 241000157278 Dacus <genus> Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000219322 Dianthus Species 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 108010002459 HIV Integrase Proteins 0.000 description 1
- 241000774429 Helichrysum aureonitens Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 108700020129 Human immunodeficiency virus 1 p31 integrase Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 241000967532 Hyptianthera Species 0.000 description 1
- 241000959361 Hyptianthera stricta Species 0.000 description 1
- APOPUTYAPYVYFW-HSZAGJOBSA-N Kadsulactone A Natural products O=C1C(C)=CC[C@@H]([C@@H](C)[C@@H]2[C@@]3(C)[C@@](C)([C@H]4[C@@]5([C@@]6([C@@H]([C@H](O)C4)C(C)(C)OC(=O)C=C6)C5)CC3)CC2)O1 APOPUTYAPYVYFW-HSZAGJOBSA-N 0.000 description 1
- TYAJEEFQBLTASC-UHFFFAOYSA-N Lancilactone C Natural products C1CC2(C)C(C=CC(C(CCC(O)=O)=C3)=C(C)C)=C3CCC2(C)C1C(C)C1CC=C(C)C(=O)O1 TYAJEEFQBLTASC-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 241001609967 Nicotiana clevelandii Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 235000012364 Peperomia pellucida Nutrition 0.000 description 1
- 241001522976 Prunus necrotic ringspot virus Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 241000219289 Silene Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000016010 Tomato spotted wilt orthotospovirus Species 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 244000042314 Vigna unguiculata Species 0.000 description 1
- 235000010722 Vigna unguiculata Nutrition 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 229940045686 antimetabolites antineoplastic purine analogs Drugs 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229930007108 beta-thujone Natural products 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000008687 biosynthesis inhibition Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229940012229 genone Drugs 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- XBFMJHQFVWWFLA-UHFFFAOYSA-N hexane;pentane Chemical compound CCCCC.CCCCCC XBFMJHQFVWWFLA-UHFFFAOYSA-N 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- APOPUTYAPYVYFW-HLNDSBHSSA-N kadsulactone a Chemical compound C([C@H]1[C@H]([C@@H]2[C@]3(CC[C@]45C[C@]55[C@H](C(OC(=O)C=C5)(C)C)[C@H](O)C[C@H]4[C@]3(C)CC2)C)C)C=C(C)C(=O)O1 APOPUTYAPYVYFW-HLNDSBHSSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229930194266 lancilactone Natural products 0.000 description 1
- TYAJEEFQBLTASC-NNIFVFKYSA-N lancilactone C Chemical compound C([C@H]1[C@H]([C@@H]2[C@]3(CCC4=C(C=CC(C(CCC(O)=O)=C4)=C(C)C)[C@]3(C)CC2)C)C)C=C(C)C(=O)O1 TYAJEEFQBLTASC-NNIFVFKYSA-N 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000000885 phytotoxic effect Effects 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 238000012809 post-inoculation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 239000005315 stained glass Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- ZEMGGZBWXRYJHK-UHFFFAOYSA-N thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 1
- 229950000329 thiouracil Drugs 0.000 description 1
- 229930007110 thujone Natural products 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- XUINKEIPBTYUJP-UHFFFAOYSA-N trans-ocimenone Natural products CC(C)=CC(=O)C=C(C)C=C XUINKEIPBTYUJP-UHFFFAOYSA-N 0.000 description 1
- -1 triterpene lactones Chemical class 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000003253 viricidal effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N27/00—Biocides, pest repellants or attractants, or plant growth regulators containing hydrocarbons
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
- A01N35/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/12—Asteraceae or Compositae [Aster or Sunflower family], e.g. daisy, pyrethrum, artichoke, lettuce, sunflower, wormwood or tarragon
Definitions
- the present invention relates to the use of Tagetes minuta oil and its components as antiviral agent. More particularly this invention relates to identification of antiviral activity of Tagetes minuta oil. This invention also relates to the use of the compounds Z- ⁇ -ocimene and dihydrotagetone present in Tagetes minuta oil which are now found to inhibit Carnation Ring Spot (CaRSV) and Carnation Vein Mottle Viruses (CaVMV).
- CaRSV Carnation Ring Spot
- CaVMVMV Carnation Vein Mottle Viruses
- Carnation Ring Spot (CaRSV) and Carnation Vein Mottle Viruses (CaVMV) are widespread in carnations and cause appreciable amount of damage.
- Production of disease free plants and chemical control of vectors are the methods employed for reducing disease incidence in the field (Matthews R. E. F. 1991, Plant Virology, Academic Press, San Diego, pp.835)
- Carnation Vein Mottle virus (CaVMV) is a member of potyvirus group, first reported from U.S.A. and is found all over the world (Kissanis B., 1954, Nature 173: 1097). On natural hosts chlorotic and darker green spots, flecks and mottling, flower breaking and malformation symptoms are developed after infection. Virus is transmitted mechanically, and also by aphid vectors.
- Chenopodium amranticolor, Chenopodium quinoa and Silene pendule are diagnostically susceptible hosts. On Chenopodium amaranticolor chlorotic and necrotic local lesions appear whereas, in Chenopodium quinoa, chlorotic lesions with systemic develop after inoculation. Chenopodium quinoa, and Dianthus barbatus are the maintenance and propagation host. It has RNA genone, which is single stranded and virions found in all parts of the host plant. (Morgan J. R., Verhoyen M. and Caneghem, G. V., 1996, Carnation Vein Mottle Potyvirus, In-Viruses of plants, Description and lists from VIDE database ed. Brunt A. A., Crabtree K., Dallwitz M. J., Gibbs A. J. and Watson L. CAB International pp 309-312).
- Carnation Ring Spot Virus first isolated from Dianthus species from U.K. by Kassanis belongs to dianthovirus group (Kassanis B., 1995, Ann. Appl. Biol. 43:103). CaRSV is found all over the world wherever carnations are grown. Virus is transmitted mechanically, and by grafting. Vector transmission is by nematodes. The virus causes leaf mottling, ring spotting, plant stunting, distortion, and flower distortion in host plants whereas, in experimentally infected plants chlorotic and necrotic local lesions, rings and flecks and occasional systemic symptom also appear.
- Virus can be maintained on Dianthus barbatus, Nicotiana clevelandii and Phaseolus vulgaris. Virions are isometric, non-enveloped 34 nm in diameter. Gonome of virus consists of RNA, linear, single stranded. Virions are found in all part of the host plant. (Termaine J. H. and Moran J. R., 1996, Carnation Ring spot virus. In-Viruses of plants, Description and lists for VIDE database ed. Brunt A. A., Crabtree K., Dallwitz M. J., Gibbs A. J., and Watson L. CAB International pp 309-312).
- the MIC Minimum Inhibitory Concentration
- the MIC was 8.73, 10.91 and 2.13 ⁇ 10 ⁇ 2 mg/ml respectively against all the three organisms.
- a number of compounds from different plant extracts have antiviral activity (Perez C., Agnese A. M. Cabrere J. L., 1999, The essential oil of Senecio graveoleus (Compositae): chemical composition and antimicrobial activity test 66:91).
- a new acelycated flavonol glycoside, quercetin exhibited IC 50 values of 18.1 ⁇ 1.3 ⁇ g/ml against HIV integrase (Kim J. H., Woo E. R., Shin C.
- the essential oil was bactericidal at ⁇ fraction (1/4000) ⁇ dilution; dilutions of up to ⁇ fraction (1/10000) ⁇ decreased bacterial growth rates.
- the essential oil of S. fructicosa and its three main components exhibited cytotoxic activity against African Green Monkey Kidney (vero) cells and high levels of virucidal activity against Herpes Simplex Virus 1 (Sivropou A., Nikolaou K. E., Kokkini S. L. and Arsenalics M., 1997, Antimicrobial, cytotoxic and antiviral activities of Saliva fruiticosa essential oil. Journal of Agriculture and Food chemistry, 45: 3197.)
- the essential oils and their components exhibited inhibiting properties against viruses (Deans S. G. and Waterman P.
- Tagetes minuta L. (Asteraceae) grows wild and yields essential oil having commercial value in perfumery and flavour industry (Handa K. L., Chopra M. M., Nigam M. C., 1963, The Essential Oil Res. 54:372).
- the essential oil produced from plants has been chemically investigated (Chopra I. C., Nigam M. C., Kapoor C. D. and Handa K. L., 1963, Indian Tagetes Oils, Soap Perfumes Cosmetics, 36, 686; Razden T. K., Wanchoo R. K. and Dhar K. L., 1986, Chemical composition and antimicrobial activity of the oil of Tagetes minuta L. Perfum. Kosmet.
- Ribavirin (Virazole) (Lozoya-Saldana H., Dawson O. and Murashige T., 1984, Effect or ribavirin and adenine arabinoside on tobacco mosaic virus in Nicotiana tabacum L. var. xanthim tissue cultures. Plant Cell Tissue Org. Cult., 3:41) Tiazofurin (Caner J. Amelia V and Vicente M, 1984, Effect of tiazofurin on tomato plants infected with tomato spotted wilt virus.
- PNRSV seems to be resistant to ribavirin (Hansen A. J. 1984, Effect of ribavirin on green ring mottle saucan agent and necrotic rings spot virus in Prunus species, Plant Dis. Rep. 68:216) and TMV is much less susceptible than other viruses, except during the very early replicative steps directly following inoculation (Dawson O. and Lozoya—Saldana H., 1984, Examination of mode of action of ribavirin against tobacco mosaic virus. Intervirology, 22:77) Ribavirin is relatively or completely ineffective against BGMV, SSV and CaMV (Kluge S.
- tiazofurin (Lerch B., 1987, on the inhibition of plant virus multiplication by ribavirin Antiviral Res., 7:257) and Pyrazofurin are tested to see antiviral effect on a range of plant viruses.
- Other synthetic antivirals are purine-based analogs 8′-azaguanine (Matthews R. E. F., 1954 Effects of some purine analogues on tobacco mosaic virus. J.Gen Microbiol 10:521), adenine arabinoside (Lozoya-Saldana H. and Dawson W. O. Rev. Mex.
- the essential oil of Melaleuca alternifolia (100, 250 or 500 ppm) was sprayed on plants of Nicotiana glutinosa inoculated before plants were inoculated with tobacco mosaic virus isolated form infected tomato leaves.
- the essential oil treatment reduced lesion number for at least 10 days post inoculation.
- Ocimum sanctum and Peperomia pellucida were evaluated for inhibitory activity against cowpea mosaic virus (CPMV), mung bean mosaic virus (MBMV), bean common mosaic virus (BCMV) and southern bean mosaic virus (SBMV).
- CPMV cowpea mosaic virus
- MBMV mung bean mosaic virus
- BCMV bean common mosaic virus
- SBMV southern bean mosaic virus
- Ocimum sanctum at 3000 ppm gave the best inhibition of 89.6, 90, 92.7, 88.2% against CMV, MBMV, BCMV, and SBMV respectively.
- the other oils also showed inhibitory activity against other viruses.
- Tagetes minuta oil was found to be active against carnation ring spot (CaRSV) and carnation vein mottle viruses (CaVMV).
- the ingredients present in the oil namely dihydrotagetone and ocimene when tested individually in pure form, were found to have enhanced antiviral activity against two carnation viruses.
- the oil as such and the bioactive consituent present in oil can be commercially used as an natural and eco-friendly antiviral products.
- the main object of the present investigation is to evaluate the antiviral activity of Tagetes minuta oil.
- Another object of the present invention is to isolate and characterize antiviral components from Tagetes minuta oil.
- Still another object of the present invention is to provide easy and convenient method to enrich Z- ⁇ -ocimene and dihydrotagetone from the tagetes oil by solvent-solvent partitioning.
- Yet another object of the present investigation is to provide control measure for carnation and for other plant viruses using natural products.
- Yet another object of the present investigation is to provide quick and efficient natural products to control Poty and Diantho group viral infection.
- FIG. 1 is a gas chromatogram of Tagetes minuta oil.
- FIG. 2 is a gas chromatogram of the acetonitrile fraction.
- FIG. 3 is a gas chromatogram of Z- ⁇ -ocimene.
- FIG. 4 is a mass spectrum representation of Z- ⁇ -ocimene.
- FIG. 5 is the 1 H NMR of Z- ⁇ -ocimene.
- FIG. 6 is the 13 C NMR of Z- ⁇ -ocimene.
- FIG. 7 is the gas chromatogram of dihydrotagetone.
- FIG. 8 is the mass spectrum representation of dihydrotagetone.
- FIG. 9 is the 1 H NMR of dihydrotagetone.
- FIG. 10 is the 13 C NMR of dihydrotagetone.
- the present investigation provides identification of antiviral activity of Tagetes minuta oil and its components which comprises of (a) Hydrodistillation of Tagetes oil (b) drying and storage of oil (c) fractionating the oil into the hydrocarbon rich fraction and ketone rich fraction by solvent-solvent partitioning (d) Isolation of dihydrotagetone and ocimene by chromatographic techniques (e) Raising of host plant (f) Application of whole oil and pure isolates in ppm concentration on leaves of Chenopodium amaranticolor.
- Tagetes minuta oil was obtained by hydro/steam distillation in laboratory/pilot scale.
- the two major constituents ocimene and dihydrotagetone were enriched in the oil by solvent-solvent partitioning.
- dihydrotagetone was tested against two carnation viruses.
- the essential oil of Tagetes minuta was produced by steam distillation in pilot plant or by hydrodistillation on Clevenger type apparatus (Clevenger J. F. 1928, J. Amer Pharm Assoc. 17:346) when the crop is matured generally during the month of Sept - Dec (India). Drying of the oil is generally done in anhydrous sodium sulphate or sodium chloride. The oil may be stored in aluminium containers or in amber coloured glass bottles, without leaving any gap of foreign particles.
- the freshly distilled Tagetes minuta oil contains ocimene 54.97%, and dihydrotegetone 32.58% 9Singh B., Sood R. P. and Singh V., 1992, chemical composition of Tagetes minuta oil from Himachal Pradesh (India) J. Essent. Oil Res. 4:1992)
- n-pentane n-hexane
- acetonitrile Final purification of these components is achieved by chromatographic separation using Silica gel (60-120 mesh). The purity of the compounds was checked with the help of TCL and GC. Other components, tagetones and ocimenones could not be isolated in pure form because these components get polymerise at faster rate.
- Tagetes crop grows wild and can be distilled in rich pockets/places with prototype distillation unit.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Agronomy & Crop Science (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pest Control & Pesticides (AREA)
- Botany (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
This invention relates to an antiviral composition for the treatment of plant viruses comprising an effective amount of Tagetes minuta oil, its active constituents, Z-β-ocimene and dihydrotagetone, or any mixture thereof. The invention also relates to the use of Tagetes minuta oil, its active constituents Z-β-ocimene and dihydrotagetone, or any mixture thereof for the treatment of plant viruses.
Description
- The present invention relates to the use ofTagetes minuta oil and its components as antiviral agent. More particularly this invention relates to identification of antiviral activity of Tagetes minuta oil. This invention also relates to the use of the compounds Z-β-ocimene and dihydrotagetone present in Tagetes minuta oil which are now found to inhibit Carnation Ring Spot (CaRSV) and Carnation Vein Mottle Viruses (CaVMV).
- Carnation Ring Spot (CaRSV) and Carnation Vein Mottle Viruses (CaVMV) are widespread in carnations and cause appreciable amount of damage. Production of disease free plants and chemical control of vectors are the methods employed for reducing disease incidence in the field (Matthews R. E. F. 1991, Plant Virology, Academic Press, San Diego, pp.835)
- Carnation Vein Mottle virus (CaVMV) is a member of potyvirus group, first reported from U.S.A. and is found all over the world (Kissanis B., 1954, Nature 173: 1097). On natural hosts chlorotic and darker green spots, flecks and mottling, flower breaking and malformation symptoms are developed after infection. Virus is transmitted mechanically, and also by aphid vectors.
-
- Carnation Ring Spot Virus (CaRSV) first isolated from Dianthus species from U.K. by Kassanis belongs to dianthovirus group (Kassanis B., 1995, Ann. Appl. Biol. 43:103). CaRSV is found all over the world wherever carnations are grown. Virus is transmitted mechanically, and by grafting. Vector transmission is by nematodes. The virus causes leaf mottling, ring spotting, plant stunting, distortion, and flower distortion in host plants whereas, in experimentally infected plants chlorotic and necrotic local lesions, rings and flecks and occasional systemic symptom also appear.
-
- The plant volatile oils have been recognised since antiquity to possess biological activity and a number of plant extracts and pure isolates have been mentioned as containing substances which interfere with or inhibit infection of viruses. Some of the compounds like galangin when used in concentrations ranging form 12-47 μg/ml showed significant antiviral activity against HSV-1 and Cox B1 (Meger J. J. M., Afoloyan A. J., Taylor M. B., Erasmus D., 1997, Antiviral activity of galangin isolated from the aerial parts ofHelichrysum aureonitens, J. Ethnopharma, 56:165). Plant Hyptianthera stricta L. is used against Encephalitis causing viruses pronounced inhibiting
activity 75% and 50% CPE inhibition at 62.5 μg/ml and 15.6 μg/ml against these two viruses (Saxena G., Gupta P., Chandra K., Lakshmi V., 1997, Antiviral activity of Hyptianthera shivta L. against encephalitis causing viruses, Indian Drugs, 34:694). The essential oil of Melaleuca alternifolia in concentration of 100, 250, 500 ppm was found to be effective in decreasing local lesions of TMV on host plant Nicotiana glutinosa (Bishop C. D., 1995, Antiviral activity of the essential oil of Melaleuca alternifolia (Maiden & Betche) cheel (Teatree) against Tobacco Mosaic Virus: J. Essen. Oil Res 7:641). The chemical composition of essential oil for Senecio graveleopeus was analysed by GLC-MS and different components like isovaleraldehyde, α-pinene, sabinene, p-cymene, terpinen-4-ol, α and β-eudesmone were identified and found to have antimicrobial activity against Microccus letus, staphylococus aureus and antifungal activity against Candida albicans. The MIC (Minimum Inhibitory Concentration) was 8.73, 10.91 and 2.13×10−2 mg/ml respectively against all the three organisms. A number of compounds from different plant extracts have antiviral activity (Perez C., Agnese A. M. Cabrere J. L., 1999, The essential oil of Senecio graveoleus (Compositae): chemical composition and antimicrobial activity test 66:91). A new acelycated flavonol glycoside, quercetin exhibited IC50 values of 18.1±1.3 μg/ml against HIV integrase (Kim J. H., Woo E. R., Shin C. G., Park 1998, Acer okamotoanum and its inhibitory activity against HIV-1 integrase. J. Natural Products 61:145). Three new triterpene lactones lancilactones A, B, C together with the known Kadsulactone A were isolated from stems and roots of Kadsura lancilimba. Their structure with sterochemistries was determined from mass and NMR.Compound 3 inhibited HIV replication with an EC50 value of 1.4 mg/ml and a therapeutic index of greater than 71.4 (Chen F. D., Zhang X. S., Wang K. H., Zhang Y. S., Sun Q. Z., Cosentine L. M., and Lee K. H. 1999, Novel Anti-HIV Lancilactone C and related Triterpense from Kadsura lancilimba J. Natural Products 62:94). Salvia fructiosa oil extracted form aerial parts was analysed by GC-MS. It contained 1,8 cineole (eucalyptol) (47.48%) α+β thujone (11.93%) and camphor (9.04%). The essential oil of S. fructiosa and its isolated components, thujone and 1,8 cineole, exhibited activity against 8 bacterial strains. Camphor was almost inactive against 8 bacterial strain. Camphor was almost inactive against all the bacteria tested. The essential oil was almost inactive against all the bacteria tested. The essential oil was bactericidal at {fraction (1/4000)} dilution; dilutions of up to {fraction (1/10000)} decreased bacterial growth rates. The essential oil of S. fructicosa and its three main components exhibited cytotoxic activity against African Green Monkey Kidney (vero) cells and high levels of virucidal activity against Herpes Simplex Virus 1 (Sivropou A., Nikolaou K. E., Kokkini S. L. and Arsenalics M., 1997, Antimicrobial, cytotoxic and antiviral activities of Saliva fruiticosa essential oil. Journal of Agriculture and Food chemistry, 45: 3197.) The essential oils and their components exhibited inhibiting properties against viruses (Deans S. G. and Waterman P. G., 1993, Biological activity of volatile oils, in: Volatile oil crops, Hay R. K. M. and Waterman P. G. Longman Scientific and Technical pp. 97) fungi (Baruah P., Sharma R. K. Singh, R. S. and Ghosh A. C. 1996, Fungicides activity of some naturally occurring essential oils against Fusarium monitiform, Journal of Essen. Oil Res 8:411) bacteria (Chalchal J. C., Carry R. P., Menut C., Lamaty Li., Malhuret R. and Chopineau, J., 1997, correlation between chemical composition and antimicrobial activity VI, Activity of some African essential oils, Journal of Essen. Oil Res. 9:67) malaria (Milnau G., Valentin A., Benoit R., Mallie M., Bastide J. M., 1997, in vitro antimalarial activity of eight essential oils, Journal of Essen. Oil Res. 9:329). These are very few reports on effects of essential oils on viruses or viral infection in either animals or plants. -
- So far only synthetic compounds have been used against plant viruses. Ribavirin (Virazole) (Lozoya-Saldana H., Dawson O. and Murashige T., 1984, Effect or ribavirin and adenine arabinoside on tobacco mosaic virus inNicotiana tabacum L. var. xanthim tissue cultures. Plant Cell Tissue Org. Cult., 3:41) Tiazofurin (Caner J. Amelia V and Vicente M, 1984, Effect of tiazofurin on tomato plants infected with tomato spotted wilt virus. Antiviral Res., 4:325) and Pyrazofurin (Lerch B., 1987, on inhibition of plant virus multiplication by ribavirin, Antiviral Res., 7:257). Synthetic compounds which inhibit virus replication are found to be effective against at least 16 plant viruses (Hansen A. J. 1989, Antiviral chemicals for plant disease control, Critical Review in Plant Sciences, 8: (1) 54). Approximately 1000 ppm ribavirin are needed to inhibit local lesion development and to prevent infection with susceptible viruses such as PVX. In callus culture, PVX was not inhibited by 100 ppm ribavirin in the medium. However, when these calli started to differentiate, 10 ppm were enough to prevent virus spread into 90% of developing shoots.
- PNRSV seems to be resistant to ribavirin (Hansen A. J. 1984, Effect of ribavirin on green ring mottle saucan agent and necrotic rings spot virus in Prunus species, Plant Dis. Rep. 68:216) and TMV is much less susceptible than other viruses, except during the very early replicative steps directly following inoculation (Dawson O. and Lozoya—Saldana H., 1984, Examination of mode of action of ribavirin against tobacco mosaic virus. Intervirology, 22:77) Ribavirin is relatively or completely ineffective against BGMV, SSV and CaMV (Kluge S. and Ortel C., Arch 1976, Priufing von virazol auf vermehrung des gurkenmosaik-virus (cucumber mosaic virus) und des nelken scheckungs-virus carnation mottle virus) Phytopathoi, Pflanzenschutz, 14:219; Caner J, Amelia V., and Vicente M. 1984, Effect of tiazofurin on tomato plants infected with tomato sported wilt virus. Antiviral Res., 4:325). In some reports, tiazofurin (Lerch B., 1987, on the inhibition of plant virus multiplication by ribavirin Antiviral Res., 7:257) and Pyrazofurin are tested to see antiviral effect on a range of plant viruses. Other synthetic antivirals are purine-based
analogs 8′-azaguanine (Matthews R. E. F., 1954 Effects of some purine analogues on tobacco mosaic virus. J.Gen Microbiol 10:521), adenine arabinoside (Lozoya-Saldana H. and Dawson W. O. Rev. Mex. 1986, Effect de ribavirin adenina arabinlosida sorbre el virus mosaico del tabac el virus moteado clorotico del chicaro de vace in vivo. Fitopatrol. 3:38, 1985, Rev. Plant Pathol 65:306) Uracils (Commoner B. and Mercer F. L. 1951, Inhibition of biosynthesis of tobacco mosaic virus by thiouracil, Nature (London), 168:113) 5-Azauracil (Cassells A. C. and Long R. D. 1982, The elimination of potato viruses X Y, S and M in meristen and explant cultures of potato in presence of virazole, Potato Res., 25:165) and other large number of cyclic compounds and non-cyclic azyne compounds (Schuster G., Heinisch L., Schulze W., Ulbright H. and Willitzer H., 1984, Antiphytovirole verbindungen mit nich and zyklischer Azin-struktur Phytopathol. Z 111:97) - Some plant extracts have also been screened for their antiviral activity but these extracts have not been exploited commercially. Only a few reports are available in which essential oils were used as antiviral agent. Most of this work done on Tobacco mosaic virus (Bishop C. D, 1995. Antiviral activity of essential oil ofMelaleuca alternifolia (Maidan & Betche) cheel (Tea tree) against tobacco mosaic virus. J. of Essen Oil Res., 1995 7:6,641).
- The essential oil ofMelaleuca alternifolia (100, 250 or 500 ppm) was sprayed on plants of Nicotiana glutinosa inoculated before plants were inoculated with tobacco mosaic virus isolated form infected tomato leaves. The essential oil treatment reduced lesion number for at least 10 days post inoculation. (Rao G. D., Pandey A. K., Shukla K., 1986, Essential oils of some higher plants vis-a-vis some legume viruses. Indian perfumer 30:4, 483-486). Essential oils of Ageratum conyzoides, Callistemon lanceolatus (C. citrinus), Carum copticum (Trachyspermum ammi) Ocimum sanctum and Peperomia pellucida were evaluated for inhibitory activity against cowpea mosaic virus (CPMV), mung bean mosaic virus (MBMV), bean common mosaic virus (BCMV) and southern bean mosaic virus (SBMV). Ocimum sanctum at 3000 ppm gave the best inhibition of 89.6, 90, 92.7, 88.2% against CMV, MBMV, BCMV, and SBMV respectively. The other oils also showed inhibitory activity against other viruses.
- Another report showed 62% inhibition against tobacco mosaic virus. The fresh hydrodistilled carrot leaves yielded 0.07% essential oil, analyzed by GLC and TLC. Constituents were identified by IR, NMR and mass spectra. Antifungal activity was tested againstColletotrichum capsici and Sclerotium rolfsii, antibacterial activity tested against E. Coli and Aeromonas sp. and antiviral activity against tobacco mosaic tobamovirus. Twenty nine compounds were identified and the major constituents were Sabinene (10.93%) linalool (14.90%), linalyl acetate (8.35%), Carvone (8.77%) of C. caprici and S. folfric by 36% and 80UV% respectively. Aeromonas sp. and E. coli were inhibited at 20% and 16% respectively (Khanna R. K., Sharma O. S., Singh A., Battacharya S. C., Sen N., Sethi K. L. 1989, The essential oil from leaves of Dacus carota Linn. Var Sativa. Proceedings of 11th International Congress of essential oils, fragrances and flavours. New Delhi India, Nov. 12-16, 1989 Vol 4 Chemistry analysis and structure 1990, 173-176).
-
- After application of whole oil ofTagetes minuta and its compounds (ocimene and dihydrotagetone) individually for antiviral activity for two carnation viruses i.e. CaVMV and CaRSV following results were observed. In case of whole oil which is applied on the half leaf of the host plant Chenopodium amaranticolor in comparison to control (Virus+Buffer only) applied on other half of leaf, number of lesions were observed. Each concentration of whole Tagetes minuta oil and its pure isolated components were applied on 10 leaves so that the average could be taken.
- The main object of the present investigation is to evaluate the antiviral activity ofTagetes minuta oil.
- Another object of the present invention is to isolate and characterize antiviral components fromTagetes minuta oil.
- Still another object of the present invention is to provide easy and convenient method to enrich Z-β-ocimene and dihydrotagetone from the tagetes oil by solvent-solvent partitioning.
- Yet another object of the present investigation is to provide control measure for carnation and for other plant viruses using natural products.
- Yet another object of the present investigation is to provide quick and efficient natural products to control Poty and Diantho group viral infection.
- FIG. 1 is a gas chromatogram ofTagetes minuta oil.
- FIG. 2 is a gas chromatogram of the acetonitrile fraction.
- FIG. 3 is a gas chromatogram of Z-β-ocimene.
- FIG. 4 is a mass spectrum representation of Z-β-ocimene.
- FIG. 5 is the1H NMR of Z-β-ocimene.
- FIG. 6 is the13C NMR of Z-β-ocimene.
- FIG. 7 is the gas chromatogram of dihydrotagetone.
- FIG. 8 is the mass spectrum representation of dihydrotagetone.
- FIG. 9 is the1H NMR of dihydrotagetone.
- FIG. 10 is the13C NMR of dihydrotagetone.
- Accordingly the present investigation provides identification of antiviral activity ofTagetes minuta oil and its components which comprises of (a) Hydrodistillation of Tagetes oil (b) drying and storage of oil (c) fractionating the oil into the hydrocarbon rich fraction and ketone rich fraction by solvent-solvent partitioning (d) Isolation of dihydrotagetone and ocimene by chromatographic techniques (e) Raising of host plant (f) Application of whole oil and pure isolates in ppm concentration on leaves of Chenopodium amaranticolor.
- In an embodiment of the present inventionTagetes minuta oil was obtained by hydro/steam distillation in laboratory/pilot scale.
- In another embodiment of the present invention the two major constituents ocimene and dihydrotagetone were enriched in the oil by solvent-solvent partitioning.
- In yet another embodiment of the present invention,Tagetes minuta oil was tested against two carnation viruses.
- In yet another embodiment of the present invention, dihydrotagetone was tested against two carnation viruses.
- In yet another embodiments of the present invention, ocimene was tested against two carnation viruses.
- The essential oil ofTagetes minuta was produced by steam distillation in pilot plant or by hydrodistillation on Clevenger type apparatus (Clevenger J. F. 1928, J. Amer Pharm Assoc. 17:346) when the crop is matured generally during the month of Sept - Dec (India). Drying of the oil is generally done in anhydrous sodium sulphate or sodium chloride. The oil may be stored in aluminium containers or in amber coloured glass bottles, without leaving any gap of foreign particles. The freshly distilled Tagetes minuta oil contains ocimene 54.97%, and dihydrotegetone 32.58% 9Singh B., Sood R. P. and Singh V., 1992, chemical composition of Tagetes minuta oil from Himachal Pradesh (India) J. Essent. Oil Res. 4:1992)
- For enrichment of two major constituents present in tagetes oil, primary fractionation of hydrocarbons and ketones (ocimene and dihydrtotagetone), it is subject to solvent-solvent partitioning using n-pentane n-hexane may also be used and acetonitrile. Final purification of these components is achieved by chromatographic separation using Silica gel (60-120 mesh). The purity of the compounds was checked with the help of TCL and GC. Other components, tagetones and ocimenones could not be isolated in pure form because these components get polymerise at faster rate.
- The whole oil ofTagetes minuta and its pure components i.e. ocimene and dihydrotagetone were tested individually with virus cultures of CaVMV and CaRSV and applied on the leaves of Chenopodium amaranticolor. In all the experiments each concentration of three testing mixtures were applied on ten leaves of Chenopodium amaranticolor palnt. The isolated compounds were stored at 0° C. for two months and the experiments were repeated.
- In 350 ml ofTagetes minuta oil, 250 ml of acetonitrile and 250 ml of n-pentane (may be replaced by n-hexane or n-heptane) were added and mixture was shaken slowly in separating funnel. This was allowed to stand for half an hour. After separating two layers, the acetonitrile layer was washed three times with n-pentane (250 ml each), the pentane fractions were combined and the solvent evaporated i.e. n-pentane from pentane fraction and acetonitrile form acetonitrile fraction. After analysing both the fractions by Gas Chromatographic technique, following percentage of ocimene (hydrocarbon) and dihydrotagetone (ketone) were observed. The freshly distilled Tagetes minuta oil contained ocimene 54.97% and dihydrotagetone 32.58%.
1. Pentane fraction Ocimene 62.5% Dihydrotagetone 24.62% 2. Acetonitrile Fraction Ocimene 26.96% Dihydrotagetone 69.87% - The enrichment of dihydrotagetone was achieved form 32.5%, present in freshly distilled oil to nearly 70% after partitioning.
- The acetonitrile fraction was subjected to the column chromatography on Silica gel (60-120 mesh), run initially with n-hexane and then with an increasing polarity with ethyl acetate upto 2% to get pure dihydrotagetone. Confirmation of dihydrotagetone was made by various analytical techniques like IR, GC, GC-MS,1H & 13C NMR spectroscopy and the odour profile was checked by the internal faculty members.
- Identification
- The identification and structure confirmation was done with the help of MS, IR,
1H—NMR and 13C—NMR. Dihydrotagetone Molecular Formula C10H18O m/e (%) 154 (10), 97 (30), 85 (100), 69 (50) 57 (65), 55 (35), 53 (18), 44 (15), 41 (60) 1H—NMR 4.89-5.02 (2H m, H-1), 5.64-5.78 (1H, m, H-2) (ppm, CDCl3) 2.68-2.75 (1H, m H-3), 2.09-2.47 (4H, m, H-4, 6) 1.11-1.26 (3H, d J = 6 Hz, H-8), 1.02-0.89 (6H, d, J = 6 Hz, H-9, 10) 13C—NMR 112.49, (C-1), 142.64 (C-2), 23.97 (C-3), 207.9 (ppm, CDCl3) (C-4), 51.94 (C-5), 49.4 (C-6) 32.75 (C-7), 32.75 (C-7), 22.23 (C-8) 19.8 (C-9), 22.23 (C-10). Ocimene Molecular Formula C10H16 m/e (%) 136 (5), 121 (15), 1.5 (19), 93 (100), 91 (52), 79 (45), 65 (15), 53 (20), 41 (27) 1H—NMR 1.55, (3H, s, H-8), 1.63 (3H, s, H-10), (ppm, CDCl3) 1.81 (3H, s, H-9), 2.85 (2H, t, J = 7.5 Hz, H-5), 5.06-5.38 (4H, m, H-1, 4, 6), 6.73-6.87 (1H, m, H-2). 13C—NMR 113.83 (C-1), 134.04 (C-2), 132.34 (C-3) (ppm, CDCl3) 130.0 (C-4), 26.85 (C-5, 122.92 (C-6) 132.34 (C-7), 18.07 (C-8) 26.03 (C-9) 20.09 (C-10) - The Cultures of Carnation ring spot and Carnation vein motto viruses were maintained both in natural host and onPhaseolus vulgaris and Chenopodium quinoa which are maintenance and propagation host of these viruses respectively. For virus culture, leaves of fifteen days old individual virus inoculated host plants with CaVMV and CaRSV were ground in phosphate buffer pH 7.5 and the viruses were extracted separately in crude sap.
- Screening of Antiviral Activity
- Activity of the above volatile oils were tested against Carnation ring spot and Carnation vein mottle virus in different dilutions. Most of the tests were performed by using 0.5% and 2.5% concentration of essential oils as the phytotoxic effect appeared onChenopodium amaranticolor leaves, at higher concentrations. The 0.5% and 2.5% concentration of essential oils were mixed with crude sap containing each virus and incubated at room temperature for 24 hrs. After incubation, sap containing virus were inoculated individually on bioassay host Chenopodium amaranticolor after adding Cellite (as abrasive) to monitor the inhibitory effect. Following results were obtained in different concentrations.
TABLE 1a Treatment of CaVMV with 0.5% Tagetes minuta oil No. of Lesions on Average No. of lesions S. No. Test Control Test Control % inhibition 1 39 713 3.9 71.1 94.5 2. 46 657 4.6 65.7 92.2 3. 42 702 4.2 70.2 94.2 -
TABLE 1b Treatment of CaRSV with 0.5% Tagetes minuta oil No. of Lesions on Average No. of lesions S. No. Test Control Test Control % inhibition 1 67 761 6.7 76.1 91.3 2. 55 769 5.5 76.9 92.8 3. 65 770 6.5 77 91.5 -
TABLE 2a Treatment of CaVMV with 2.5% Tagetes minuta oil No. of Lesions on Average No. of lesions S. No. Test Control Test Control % inhibition 1 82 699 8.2 69.9 88.2 2. 76 648 7.6 64.8 88.2 3. 70 655 7.0 65.5 89.3 -
TABLE 2b Treatment of CaRSV with 2.5% Tagetes minuta oil No. of Lesions on Average No. of lesions S. No. Test Control Test Control % inhibition 1 73 582 7.3 58.2 87.45 2. 77 624 7.7 62.4 87.6 3. 75 612 7.5 61.2 87.7 -
TABLE 3a Treatment of CaVMV with 0.5% Dihydrotagetone No. of Lesions on Average No. of lesions S. No. Test Control Test Control % inhibition 1 38 141 4.22 15.66 73.04 2. 40 150 4.44 15.66 73.3 3. 45 152 5.00 15.70 70.3 -
TABLE 3b Treatment of CaRSV with 0.5% Dihydrotagetone No. of Lesions on Average No. of lesions S. No. Test Control Test Control % inhibition 1 32 115 4.22 15.66 72.1 2. 41 141 4.44 15.66 70.9 3. 42 150 5.00 15.70 72.0 -
TABLE 4a Treatment of CaVMV with 2.5% Dihydrotagetone No. of Lesions on Average No. of lesions S. No. Test Control Test Control % inhibition 1 31 183 3.44 20.33 83.0 2. 25 192 2.77 21.33 87.0 3. 38 200 4.20 22.22 81.0 -
TABLE 4b Treatment of CaRSV with 2.5% Dihydrotagetone No. of Lesions on Average No. of lesions S. No. Test Control Test Control % inhibition 1 82 155 2.8 15.5 81.8 2. 25 140 2.5 14.0 82.0 3. 40 195 4.0 19.5 79.4 -
TABLE 5a Treatment of CaVMV with 0.5% Ocimene No. of Lesions on Average No. of lesions S. No. Test Control Test Control % inhibition 1 66 228 6.6 22.8 71.05 2. 70 215 7.0 21.5 63.50 3. 65 233 6.5 23.3 72.1 -
TABLE 5b Treatment of CaRSV with 0.5% Ocimene No. of Lesions on Average No. of lesions S. No. Test Control Test Control % inhibition 1 60 198 6.0 19.8 69.6 2. 65 195 6.5 19.5 66.6 3. 58 180 5.8 18.0 67.7 -
TABLE 6a Treatment of CaVMV with 2.5% Ocimene No. of Lesions on Average No. of lesions S. No. Test Control Test Control % inhibition 1 43 262 4.3 26.8 83.58 2. 40 250 4.0 25.0 84.00 3. 38 265 3.8 26.5 85.66 -
TABLE 6b Treatment of CaRSV with 2.5% Ocimene No. of Lesions on Average No. of lesions S. No. Test Control Test Control % inhibition 1 40 205 4.0 20.5 80.4 2. 25 135 2.5 13.5 81.4 3. 35 185 3.5 18.5 81.0 - When these pure isolated compounds were stored at 0° C. for two months, following results were obtained.
TABLE 7a Treatment of CaVMV with DHT (stored at 0° C. for two months) 0.5% concentration 2.5% concentration S. No. Test Control Test Control 1. 0 158 0 200 2. 0 170 0 185 3. 0 165 0 189 -
TABLE 7b Treatment of CaRSV with DHT (stored at 0° C. for two months) 0.5% concentration 2.5% concentration S. No. Test Control Test Control 1. 0 141 0 195 2. 0 168 0 188 3. 0 166 0 190 -
TABLE 8a Treatment of CaVMV with Ocimene (stored at 0° C. for two months) 0.5% concentration 2.5% concentration S. No. Test Control Test Control 1. 0 200 0 262 2. 0 250 0 285 3. 0 260 0 203 -
TABLE 8b Treatment of CaRSV with Ocimene (stored at 0° C. for two months) 0.5% concentration 2.5% concentration S. No. Test Control Test Control 1. 0 210 0 267 2. 0 235 0 282 3. 0 216 0 213 -
TABLE 9a Percentage Inhibition of CaVMV with Three Treatments Compo- Ist Treatment Compo- IInd Treatment IIIrd Treatment nent 0.5% 2.5% nent 0.5% 2.5% 0.5% 2.5% Whole 93.8 88.5 Ocimene 70.2 84.3 100 100 oil Dihydro- 72.2 83.6 100 100 tegetone -
TABLE 9b Percentage Inhibition of CaRSV with Three Treatments Compo- Ist Treatment Compo- IInd Treatment IIIrd Treatment nent 0.5% 2.5% nent 0.5% 2.5% 0.5% 2.5% Whole 91.5 87.5 Ocimene 67.9 80.9 100 100 oil Dihydro- 71.6 81.06 100 100 tegetone - The main advantages of the present invention are:
- 1.Tagetes minuta plant grows wild in the hilly areas like Himachal Pradesh, Jammu and Kashmir, Uttar Pradesh, North Eastern States of India, and cultivated as commercial Tagetes oil crop hence easily available in bulk quality.
- 2. The oil and pure isolates are natural products and hence no threat to environment.
- 3. Application of oil and pure isolates ensure quick and efficient recovery from viral infections.
- 4. It also helps in the plant virus management.
- 5. Tagetes crop grows wild and can be distilled in rich pockets/places with prototype distillation unit.
- 6. A cheap, eco-friendly and easily available anti-viral natural product.
Claims (11)
1. An antiviral composition for the treatment of plant viruses comprising an effective amount of Tagetes minuta oil.
2. An antiviral composition for the treatment of plant viruses comprising an effective amount of Tagetes minuta oil, and its active constituents, Z-β-ocimene and dihydrotagetone.
3. An antiviral composition for the treatment of plant viruses comprising an effective amount of an active ingredient selected from Z-β-ocimene and dihydrotagetone.
4. Use of Tagetes minuta oil and its constituents, Z-β-ocimene and dihydrotagetone to inhibit growth poty and diantho virus groups.
5. Use of Tagetes minuta oil to inhibit growth poty and diantho virus groups.
6. Use of Tagetes minuta to inhibit the growth of Carnation Vein Mottle (CaVMV) virus.
7. Use of Z-β-ocimene to inhibit the growth of Carnation Vein Mottle (CaVMV) virus.
8. Use of dihydrotagetone to inhibit the growth of Carnation Vein Mottle (CaVMV) virus.
9. Use of Tagetes minuta to inhibit the growth of Carnation Ring Spot Viruses (CaRSV).
10. Use of Z-β-ocimene to inhibit the growth of Carnation Ring Spot Viruses (CaRSV).
11. Use of dihydrotagetone to inhibit the growth of Carnation Ring Spot Virus (CaVMV).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/765,075 US6444458B1 (en) | 2001-01-18 | 2001-01-18 | Use of tagetes minuta oil and its components as antiviral agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/765,075 US6444458B1 (en) | 2001-01-18 | 2001-01-18 | Use of tagetes minuta oil and its components as antiviral agents |
Publications (2)
Publication Number | Publication Date |
---|---|
US6444458B1 US6444458B1 (en) | 2002-09-03 |
US20020136789A1 true US20020136789A1 (en) | 2002-09-26 |
Family
ID=25072569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/765,075 Expired - Fee Related US6444458B1 (en) | 2001-01-18 | 2001-01-18 | Use of tagetes minuta oil and its components as antiviral agents |
Country Status (1)
Country | Link |
---|---|
US (1) | US6444458B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005053395A2 (en) * | 2003-12-02 | 2005-06-16 | Plant Impact Plc | Pesticidal compositions |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030186812A1 (en) * | 2002-03-22 | 2003-10-02 | Amitabha Chattopadhyay | Synergistic formulation as plant growth regulator |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5662915A (en) * | 1995-02-01 | 1997-09-02 | Okioga; David Mocheo | Pesticide product derived from the plant Tagetes minuta |
-
2001
- 2001-01-18 US US09/765,075 patent/US6444458B1/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005053395A2 (en) * | 2003-12-02 | 2005-06-16 | Plant Impact Plc | Pesticidal compositions |
GB2411117A (en) * | 2003-12-02 | 2005-08-24 | Biofutures Pi Ltd | Pesticidal compositions |
WO2005053395A3 (en) * | 2003-12-02 | 2005-11-03 | Plant Impact Plc | Pesticidal compositions |
GB2411117B (en) * | 2003-12-02 | 2005-11-23 | Biofutures Pi Ltd | Pesticidal composition |
US20070009616A1 (en) * | 2003-12-02 | 2007-01-11 | David Marks | Pesticidal compositions |
US7816410B2 (en) | 2003-12-02 | 2010-10-19 | Biofutures PI Ltd. | Pesticidal compositions |
Also Published As
Publication number | Publication date |
---|---|
US6444458B1 (en) | 2002-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Benelli et al. | Phytol,(E)-nerolidol and spathulenol from Stevia rebaudiana leaf essential oil as effective and eco-friendly botanical insecticides against Metopolophium dirhodum | |
do Prado Ribeiro et al. | Annona mucosa Jacq.(Annonaceae): a promising source of bioactive compounds against Sitophilus zeamais Mots.(Coleoptera: Curculionidae) | |
Bernard et al. | Insecticidal defenses of Piperaceae from the neotropics | |
Keskitalo et al. | Variation in volatile compounds from tansy (Tanacetum vulgare L.) related to genetic and morphological differences of genotypes | |
Moreno et al. | Bioactivity of compounds from Acmella oleracea against Tuta absoluta (Meyrick)(Lepidoptera: Gelechiidae) and selectivity to two non‐target species | |
da Silva | Mining the essential oils of the Anthemideae | |
Shaalan et al. | A review of botanical phytochemicals with mosquitocidal potential | |
Batish et al. | Alternative control of littleseed canary grass using eucalypt oil | |
Umpiérrez et al. | Essential oils from Asteraceae as potential biocontrol tools for tomato pests and diseases | |
Kyarimpa et al. | Essential oil and composition of Tagetes minuta from Uganda. Larvicidal activity on Anopheles gambiae | |
Andrés et al. | Nematicidal potential of hydrolates from the semi industrial vapor-pressure extraction of Spanish aromatic plants | |
MX2011013304A (en) | Methods of inhibiting, preventing, killing and/or repelling insects using simulated blends of chenopodium extracts. | |
Sosa et al. | Insecticidal and nematicidal essential oils from Argentinean Eupatorium and Baccharis spp. | |
Niogret et al. | Attraction and electroantennogram responses of male Mediterranean fruit fly to volatile chemicals from Persea, Litchi and Ficus wood | |
González-Coloma et al. | Chemical and biological profiles of Lavandula luisieri essential oils from western Iberia Peninsula populations | |
Sun et al. | Effects of aphid herbivory on volatile organic compounds of Artemisia annua and Chrysanthemum morifolium | |
Tampe et al. | Repellent effect and metabolite volatile profile of the essential oil of Achillea millefolium against Aegorhinus nodipennis (Hope)(Coleoptera: Curculionidae) | |
Schildknecht | Irritant and defense substances of higher plants—A chemical herbarium | |
US6444458B1 (en) | Use of tagetes minuta oil and its components as antiviral agents | |
Murugesan et al. | Environmentally benign Solanum torvum (Sw.)(Solanaceae) leaf extract in ecofreindly management of human disease vector, Aedes aegypti (Linn.) | |
Sumitha et al. | Potential larvicidal principles in Eryngium foetidum L.(Apiaceae), an omnipresent weed, effective against Aedes albopictus skuse | |
El-Solimany et al. | Effective and eco-friendly botanical insecticidal agents against Spodoptera frugiperda (Noctuidae: Lepidoptera) using the essential oil of Stevia rebaudiana | |
Kaliyannagounder et al. | GC–MS profiling of phytocompounds in the leaves of Vitex negundo L. | |
Zhang et al. | Volatiles from essential oils of three Lamiaceae plants repel the winged cotton aphid, disturb its feeding behavior and reduce its fecundity | |
Kabdal et al. | Phytochemical composition, in vitro bioactivity evaluation and in silico molecular docking study of fruit essential oils of Zanthoxylum armatum DC collected from Himalayan region of Uttarakhand, India |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH, IND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SINGH, BIKRAM;JOSHI, VIRENDRA PRASAD;RAM, RAJA;AND OTHERS;REEL/FRAME:012150/0902 Effective date: 20010827 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Expired due to failure to pay maintenance fee |
Effective date: 20140903 |